“We have records of children between 7000 to 10,000 missing various vaccines including BCG across the county, our goal is to track them down and ensure they receive the lifesaving vaccines ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

In a recent Sermo survey of 100 U.S. urologists, 57 percent indicated they were unable to treat patients in the last 12 months due to a lack of access to TICE ® BCG. The alternative BCG source ...

Additionally, a Phase II clinical trial was conducted with rBCG in HIV-unexposed and HIV-exposed, BCG-naïve newborn infants for clinical bridging. Clinical trials have also been conducted to ...

A new BCG survey highlights significant dissatisfaction among women with consumer goods, financial services, and healthcare ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Data on rBCG is also available from studies assessing it as a tuberculosis (TB) vaccine. These studies include 2 trials in healthy adult participants, 1 in healthy newborn infants, and a trial in ...

A recent study suggests that sequential intravesical treatment with gemcitabine and docetaxel is more effective than additional bacillus Calmette-Guérin (BCG) therapy for patients with BCG ...